EC Number | General Stability | Organism |
---|---|---|
3.4.19.6 | inclusion of 50% glycerol prevents most of the harmful effect of freezing in imidazole buffer | Cavia porcellus |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.4.19.3 | Acid thyroliberin | competitive inhibition of thyroliberin hydrolysis | Cavia porcellus | |
3.4.19.3 | Anorexogenic peptide | competitive inhibition of thyroliberin hydrolysis | Cavia porcellus | |
3.4.19.3 | bradykinin-potentiating peptide 5a | competitive inhibition of thyroliberin hydrolysis | Cavia porcellus | |
3.4.19.3 | Eledoisin | competitive inhibition of thyroliberin hydrolysis | Cavia porcellus | |
3.4.19.3 | Luliberin | competitive inhibition of thyroliberin hydrolysis | Cavia porcellus | |
3.4.19.3 | neurotensin | competitive inhibition of thyroliberin hydrolysis | Cavia porcellus | |
3.4.19.6 | Luliberin | inhibits hydrolysis of thyroliberin competitively | Cavia porcellus | |
3.4.19.6 | Peptides containing N-terminal pyroglutamyl residues | - |
Cavia porcellus |
EC Number | KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
3.4.19.3 | 0.04 | - |
Thyroliberin | - |
Cavia porcellus | |
3.4.19.6 | 0.04 | - |
Thyroliberin | - |
Cavia porcellus |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
3.4.19.3 | membrane | synaptosomal | Cavia porcellus | 16020 | - |
3.4.19.6 | synaptosome | - |
Cavia porcellus | - |
- |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.4.19.3 | Cavia porcellus | - |
- |
- |
3.4.19.6 | Cavia porcellus | - |
- |
- |
EC Number | Purification (Comment) | Organism |
---|---|---|
3.4.19.3 | - |
Cavia porcellus |
3.4.19.6 | - |
Cavia porcellus |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
3.4.19.3 | brain | - |
Cavia porcellus | - |
3.4.19.6 | brain | - |
Cavia porcellus | - |
EC Number | Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|---|
3.4.19.3 | 0.323 | - |
- |
Cavia porcellus |
3.4.19.6 | 0.3237 | - |
- |
Cavia porcellus |
EC Number | Storage Stability | Organism |
---|---|---|
3.4.19.6 | -20°C, potassium phosphate buffer, pH 7.4, stable for 6 months | Cavia porcellus |
3.4.19.6 | 15°C, 5% loss of activity after 7 days | Cavia porcellus |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.4.19.3 | 5-pyrrolidone-2-carboxyl-His-Gly + H2O | slight activity | Cavia porcellus | ? | - |
? | |
3.4.19.3 | 5-pyrrolidone-2-carboxyl-His-Trp + H2O | - |
Cavia porcellus | ? | - |
? | |
3.4.19.3 | acid-thyroliberin + H2O | - |
Cavia porcellus | pyroglutamate + His-Pro | - |
? | |
3.4.19.3 | additional information | no hydrolysis of dipeptides containing N-terminal pyroglutamic acid or with pyroglutamyl peptides containing more than three amino acids | Cavia porcellus | ? | - |
? | |
3.4.19.3 | thyroliberin + H2O | - |
Cavia porcellus | pyroglutamate + His-Pro-NH2 | - |
? | |
3.4.19.6 | acid-thyroliberin + H2O | - |
Cavia porcellus | ? | - |
? | |
3.4.19.6 | luliberin N-terminal tripeptide + H2O | pyroglutamyl-His-Trp | Cavia porcellus | ? | - |
? | |
3.4.19.6 | additional information | no hydrolysis of pyroglutamyl peptides containing more than three amino acids | Cavia porcellus | ? | - |
? | |
3.4.19.6 | additional information | no hydrolysis of dipeptides containing N-terminal pyroglutamic acid | Cavia porcellus | ? | - |
? | |
3.4.19.6 | pyroglutamyl-His-Gly + H2O | slight | Cavia porcellus | pyroglutamate + His-Gly | - |
? | |
3.4.19.6 | thyroliberin + H2O | - |
Cavia porcellus | pyroglutamic acid + His-Pro-NH2 | - |
? |